Clinical Trial Update: CogT BEEM Study (a tDCS Study) [NA]

View source ↗

Summary

A completed clinical trial (CogT BEEM Study) investigating tDCS for mild cognitive impairment and neuropsychiatric syndrome; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Neuropsychiatric Syndrome

Drugs mentioned

• tDCS (transcranial direct current stimulation)

Snippet

Sponsor: University of Rochester | Conditions: Mild Cognitive Impairment, Neuropsychiatric Syndrome | NA | Status: COMPLETED | Results posted: 2023-11-07